Cargando…
The need for uniform and coordinated practices involving centrally manufactured cell therapies
Cellular therapies have become an important part of clinical care. The treatment of patients with cell therapies often involves the collection of autologous cells at the medical center treating the patient, the shipment of these cells to a centralized manufacturing site, and the return of the cryopr...
Autores principales: | Stroncek, David, Dinh, Anh, Rai, Herleen, Zhang, Nan, Somerville, Rob, Panch, Sandhya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036766/ https://www.ncbi.nlm.nih.gov/pubmed/35468789 http://dx.doi.org/10.1186/s12967-022-03385-9 |
Ejemplares similares
-
Point-of-care cell therapy manufacturing; it’s not for everyone
por: Stroncek, David F., et al.
Publicado: (2022) -
Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy
por: Shao, Lipei, et al.
Publicado: (2022) -
Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays
por: Ma, Jinxia, et al.
Publicado: (2023) -
Need for Uniform Definitions in Newborn Screening for SCID: The Next Challenge for Screeners and Immunologists
por: van der Burg, Mirjam
Publicado: (2021) -
Building the global vaccine manufacturing capacity needed to respond to pandemics
por: Sell, Tara Kirk, et al.
Publicado: (2021)